Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hopstem Biotechnology Co., Ltd. was founded in January 2017, by neuroscientists and stem-cell biologists from Johns Hopkins University. Hopstem holds world-leading expertise in neural differentiation, cell banking and cell engineering of human induced pluripotent stem cells (iPSCs) and human embryonic stem cells (ESCs). The major aims of our company are to apply these cutting-edge technologies to promote biomedical research, d...
Hopstem Biotechnology Co., Ltd. was founded in January 2017, by neuroscientists and stem-cell biologists from Johns Hopkins University. Hopstem holds world-leading expertise in neural differentiation, cell banking and cell engineering of human induced pluripotent stem cells (iPSCs) and human embryonic stem cells (ESCs). The major aims of our company are to apply these cutting-edge technologies to promote biomedical research, diagnoses and therapies of neurological and other disorders. Our products/services include different types of high quality human neural cells (HopCellTM neural cells), 2D and 3D models of human nervous system diseases

List your booth number for exhibitions, ask us